Unknown

Dataset Information

0

Structures of the Staphylococcus aureus ribosome inhibited by fusidic acid and fusidic acid cyclopentane.


ABSTRACT: The antibiotic fusidic acid (FA) is used to treat Staphylococcus aureus infections. It inhibits protein synthesis by binding to elongation factor G (EF-G) and preventing its release from the ribosome after translocation. While FA, due to permeability issues, is only effective against gram-positive bacteria, the available structures of FA-inhibited complexes are from gram-negative model organisms. To fill this knowledge gap, we solved cryo-EM structures of the S. aureus ribosome in complex with mRNA, tRNA, EF-G and FA to 2.5 Å resolution and the corresponding complex structures with the recently developed FA derivative FA-cyclopentane (FA-CP) to 2.0 Å resolution. With both FA variants, the majority of the ribosomal particles are observed in chimeric state and only a minor population in post-translocational state. As expected, FA binds in a pocket between domains I, II and III of EF-G and the sarcin-ricin loop of 23S rRNA. FA-CP binds in an identical position, but its cyclopentane moiety provides additional contacts to EF-G and 23S rRNA, suggesting that its improved resistance profile towards mutations in EF-G is due to higher-affinity binding. These high-resolution structures reveal new details about the S. aureus ribosome, including confirmation of many rRNA modifications, and provide an optimal starting point for future structure-based drug discovery on an important clinical drug target.

SUBMITTER: Gonzalez-Lopez A 

PROVIDER: S-EPMC11190147 | biostudies-literature | 2024 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Structures of the Staphylococcus aureus ribosome inhibited by fusidic acid and fusidic acid cyclopentane.

González-López Adrián A   Larsson Daniel S D DSD   Koripella Ravi Kiran RK   Cain Brett N BN   Chavez Martin Garcia MG   Hergenrother Paul J PJ   Sanyal Suparna S   Selmer Maria M  

Scientific reports 20240620 1


The antibiotic fusidic acid (FA) is used to treat Staphylococcus aureus infections. It inhibits protein synthesis by binding to elongation factor G (EF-G) and preventing its release from the ribosome after translocation. While FA, due to permeability issues, is only effective against gram-positive bacteria, the available structures of FA-inhibited complexes are from gram-negative model organisms. To fill this knowledge gap, we solved cryo-EM structures of the S. aureus ribosome in complex with m  ...[more]

Similar Datasets

2008-08-25 | GSE12210 | GEO
| S-EPMC2583067 | biostudies-literature
| S-EPMC2981276 | biostudies-literature
| S-EPMC1865894 | biostudies-literature
| S-EPMC3226684 | biostudies-literature
| S-EPMC2681530 | biostudies-literature
| S-EPMC5601635 | biostudies-literature
| S-EPMC3436278 | biostudies-literature
| S-EPMC4415905 | biostudies-literature
| S-EPMC7325228 | biostudies-literature